Esophageal Spasm: Diagnosis and Treatment
Diagnostic Approach
High-resolution esophageal manometry is the gold standard for diagnosing distal esophageal spasm, defined by at least two premature contractions (distal latency <4.5 seconds) with normal lower esophageal sphincter relaxation. 1
Initial Evaluation
Perform endoscopy first to exclude GERD, eosinophilic esophagitis, and structural abnormalities before attributing symptoms to esophageal spasm, as GERD frequently coexists and may be the primary driver of symptoms 2, 1, 3
Order high-resolution manometry after normal endoscopy to diagnose subtle presentations of esophageal spasm, as it has superior sensitivity to conventional manometry for recognizing atypical motor disorders 2
- Classic manometric criteria: >10% of wet swallows showing simultaneous and/or premature contractions intermixed with normal peristalsis 4
- Chicago classification criteria: at least two premature contractions with distal latency <4.5 seconds in the context of normal esophagogastric junction relaxation 1
Consider barium esophagram as a complementary diagnostic tool, recognizing that radiographic patterns have low sensitivity and specificity but may capture intermittent spasm episodes 4, 3
Critical Diagnostic Pitfall
Always investigate or empirically treat GERD first, as gastroesophageal reflux frequently coexists with esophageal spasm and may be the actual cause of symptoms rather than the motor disorder itself 1, 3
Treatment Algorithm
Step 1: Empiric Acid Suppression (First-Line)
Begin with a 4-8 week trial of twice-daily PPI therapy (e.g., omeprazole 20 mg before breakfast and dinner), as GERD is a common underlying or contributing factor in esophageal spasm 2, 1, 3
- This approach addresses the frequent coexistence of GERD and esophageal spasm 1
- Acid suppression therapy is widely used clinically despite limited controlled trial data specifically for esophageal spasm 1, 3
Step 2: Smooth Muscle Relaxants (If PPI Fails)
Add calcium channel blockers or long-acting nitrates as the next therapeutic step for persistent symptoms 1, 5, 3
- Calcium channel blockers (e.g., diltiazem) reduce esophageal contractile force and show manometric improvement, though clinical symptom relief may be modest 5, 3
- Nitrates (both short and long-acting) work through the nitric oxide pathway, which is deficient in esophageal spasm 1, 3
- These agents can be used alone or in combination with anticholinergics 5
Step 3: Visceral Analgesics (For Refractory Pain)
Consider tricyclic antidepressants or SSRIs for patients with persistent chest pain despite smooth muscle relaxants 1, 3
- These centrally acting drugs address the psychological component of symptom perception and provide visceral analgesia 1, 5
- Particularly useful when there is evidence of esophageal hypervigilance or hypersensitivity 2
Step 4: Botulinum Toxin Injection (For Selected Refractory Cases)
Botulinum toxin injection into the distal esophagus may be effective for patients who fail medical therapy 1, 3
- Reserve this approach for non-responders to pharmacologic therapy 3
- Important caveat: Monitor for development of post-injection gastroesophageal reflux, which requires further assessment 1
Step 5: Invasive Interventions (Last Resort)
Pneumatic dilation or surgical myotomy with fundoplication represent options for rare refractory patients 1, 5, 3
- Heller myotomy combined with fundoplication is the traditional surgical approach 1, 6
- Per-oral endoscopic myotomy (POEM) is an emerging alternative endoscopic technique 1
- These are "heroic approaches" reserved for patients who fail all medical and botulinum toxin therapies 3
Key Clinical Considerations
Natural History Warning
Be aware that esophageal spasm can progress to achalasia in some patients, requiring periodic reassessment if symptoms change 1
Diagnostic Limitation
Given the intermittent nature of esophageal spasm, it is almost impossible to definitively rule out the disorder with a single negative test 4
Treatment Reality Check
Medical therapy for primary esophageal motility disorders has limited efficacy and poor clinical results overall, with the exception of botulinum toxin for achalasia 5